• Home
  • About Symbio
  • Therapeutic Expertise
    • Dermatology
  • Topical Formulation
  • White Papers
  • Sponsors
  • Investigators
  • News & Events
  • Careers
  • Contact
USA: (631) 474-8531
  • News & Events
  • Careers
  • Contact
  • About Symbio
  • Therapeutic Expertise
    • Dermatology
  • Topical Formulation
  • White Papers
  • Sponsors
  • Investigators
  • Become an Investigator
  • Become a Sponsor

EADV Congress 2022 – a Success for Symbio and Dow

Posted on January 31, 2023February 23, 2023 by sradmin
Posted in News

Symbio and Dow Development Laboratories exhibited at EADV Congress 2022 in Milan in September. We met many amazing people and connected with both old friends and new. See you in 2023 in Seville!

 

Posted in News

Post navigation

Symbio Releases White Paper: “The Clinical State of Psoriasis”
Symbio Releases White Paper: “Atopic Dermatitis – Considerations for Clinical Trials”

Headquartered in Port Jefferson, NY, USA, Symbio is a client-focused global full-service Clinical Research Organization (CRO). We manage all CRO core services in house and have offices in the USA and Europe.

  • Symbio, LLC 21 Perry Street
    Port Jefferson, NY 11777
    Tel: (631) 474-8531
  • Symbio in Europe: SRE GmbH Karl-Breuing-Str. 2
    45770 Marl, Germany
    Tel: +49 170 205 13 58

Follow Us

Menu

  • Home
  • About Symbio
  • Therapeutic Expertise
  • Topical Formulation
  • Sponsors
  • Investigators
  • News & Events
  • Careers
  • Contact

Join Our Email List
© 2018–2023 Symbio, LLC | Exceeding Expectations in Clinical Research | Site Map | All Rights Reserved | Privacy Policy.
Designed and developed by Progressive Marketing Group, Inc.